Stock BOD BOD SCIENCE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Bod Science Limited

Equities

BOD

AU0000181331

Market Closed - Australian S.E.
Other stock markets
 23:59:52 2023-11-22 EST 		5-day change 1st Jan Change
0.024 AUD -7.69% Intraday chart for Bod Science Limited -.--% -.--%
03-25 Bod Science Announces Delay in Appendix 4D Lodgement MT
2023 BOD Science Signs Supply Agreement in Medicinal Cannabis with Green Farmers MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bod Science Announces Delay in Appendix 4D Lodgement
MT
BOD Science Signs Supply Agreement in Medicinal Cannabis with Green Farmers
MT
Bod Science Limited Enters into Supply Agreement with Green Farmers
CI
Bod Science Receives AU$1.6 Million R&D Tax Refund; Shares Rise 8%
MT
Bod Expects to Receive Funds from Antah Soon
MT
Bod Science Delays Settlement of Tranche 1 of AU$2.1 Million Placement
MT
Bod Science Raises AU$2.1 Million Via Share Placement; Shares Fall 43%
MT
Bod Science Limited announced that it expects to receive AUD 2.05 million in funding
CI
Australian Shares Retreat as Monthly CPI Indicator Rises
MT
Bod Science Validates Greater Bioavailability of Drug Delivery Technology; Shares Rally 12%
MT
Bod Science Limited Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Bod Science Limited Announces Change of Principal Place of Business
CI
Bod Science Completes Acquisition of Drug Delivery Technology; Shares Up 3%
MT
Bod Australia Limited completed the acquisition of Aqua Phase Ltd.
CI
Bod Science Validates Bioavailability of Aqua Phase Technology
MT
Bod Science Signs Letter of Intent to Sell Medical Cannabis Products in Malaysia
MT
US Debt Ceiling Caution Dampens Appetite for Australian Equities
MT
Bod Australia Secures Ethics Approval for Drug Delivery Study; Shares Jump 10%
MT
Bod Science Limited Announces David Baker Assumes an Additional Advisory Role to Support Management to Progress A Number of Commercial Initiatives
CI
BOD Science Completes Recruiting for Phase IIb Clinical Trial of CBD Product
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BOD Stock
  4. News Bod Science Limited